What is The Cigna Group (CI) DCF Fair Value and Intrinsic Value in 2026?

The Cigna Group (CI) intrinsic value is calculated using conservative multi-stage Discounted Cash Flow (DCF) models, 5-year free cash flow trajectories, Graham Numbers, and owner earnings multiples. LocalAlpha tracks real-time margin of safety against live market prices.

What is The Cigna Group's historical Return on Invested Capital (ROIC) and Moat Rating?

The Cigna Group operates in the Healthcare sector (Healthcare Plans) with an economic moat rating of NARROW. LocalAlpha tracks 5-year audited quarterly ROIC, operating margin stability, and balance sheet solvency ratios.

What is The Cigna Group's financial health rating and Piotroski F-Score?

The Cigna Group's balance sheet quality is evaluated using the 9-point Piotroski F-Score, Altman Z-Score solvency model, debt-to-equity ratio, and quick/current liquidity coverage to guard against financial distress.

How does LocalAlpha monitor The Cigna Group (CI) for quarterly SEC filing thesis breaks?

LocalAlpha audits The Cigna Group's 10-K, 10-Q, and 8-K regulatory filings on SEC EDGAR within 15 minutes of release. If reported metrics breach an investor's custom ROIC floor, operating margin boundary, or qualitative risk criteria, an autonomous breach audit is dispatched immediately.

StocksCI

CI

The Cigna GroupHealthcare / Healthcare PlansINTACT

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Share Price

$280.76

52W: $239.51 - $315.47

DCF Fair Value

$480.64

+41.6% MoS

Thesis Hub

P/E (TTM)

11.6x

ROIC

Operating Margin

FCF Yield

10.8%

Debt / Equity

0.74x

Piotroski Score

6/9

Altman Z-Score

8.13

Market Cap

$74.2B

Price vs. Intrinsic Value Corridor

Margin of Safety Buy Zone (<25% Discount)

Historical market price overlaid against conservative DCF Fair Value & Benjamin Graham Margin of Safety bands.

Period Return (1Y)

—()

Period Range

$— - $—

DCF Fair Value

$480.64

MOS Buy Target (-25%)

$360.48

Valuation Overlays: DCF Fair Value ($480.64) 25% MOS Buy Target ($360.48) Revised Graham ($365.57) Graham Number ($296.47)

2-Stage Discounted Cash Flow (DCF) Workbench

Conservative intrinsic value model based on owner cash generation over a 10-year investment horizon. Opens with LocalAlpha's baseline assumptions (matching the fair value shown above) — adjust any input to stress-test.

Current Market Price

$280.76

DCF Fair Value

$480.34

+41.5% MoS

Starting Free Cash Flow ($M)$7,980M

$100M$7,980M (Reported)$50,000M

Stage 1 Growth (Years 1-5)5.3%

-5%10% (Target)35%

Stage 2 Growth (Years 6-10)4.5%

0%5%20%

Discount Rate (WACC / Hurdle)9.0%

6%9% (Standard)15% (High Risk)

Terminal Perpetual Growth2.5%

1% (GDP Floor)2.5% (Inflation)4.0%

Net Debt ($M)$24,600M

-$100B CashBalance Sheet+$150B Debt

10-Yr PV of Cash Flows

$65.7B

PV of Terminal Value

$85.8B

Implied Enterprise Value

$151.4B

Implied Equity Value

$126.8B

Year	Yr 1	Yr 2	Yr 3	Yr 4	Yr 5	Yr 6	Yr 7	Yr 8	Yr 9	Yr 10
Projected FCF ($M)	$8,403	$8,848	$9,317	$9,811	$10,331	$10,796	$11,282	$11,789	$12,320	$12,874
Present Value (PV)	$7,709	$7,447	$7,195	$6,950	$6,714	$6,437	$6,172	$5,917	$5,672	$5,438

Benjamin Graham & Buffett Value Models

Classical deep value metrics based on asset backing, normalized earnings power, and owner cash yield.

Graham Number+5.3%

$296.47

Calculated as √(22.5 × EPS × BVPS). The maximum theoretical price a defensive investor should pay based purely on asset book value and current earnings.

EPS: $24.17BVPS: $161.62

Revised Graham Formula+23.2% MoS

$365.57

Formula: V = (EPS × (8.5 + 2g) × 4.4) / Y where g is the conservative 7-10 yr growth rate and Y is AAA Bond Yield.

Growth Rate (g%)

Bond Yield (Y%)

Buffett Owner Earnings10.2% Yield

$28.72 / share

True distributable cash flow: Net Income + D&A - Maintenance CapEx. Reflects the cash Buffett would extract without hurting unit volume.

Total: $7.6BYield: 10.2%

Reverse DCF: Market Growth Expectation

EXTREMELY LOW BARRIER

-4.7% CAGR (Next 10 Yrs)

At the current price of $280.76, the market is assuming the business will compound Free Cash Flow at -4.7% per year for the next decade with a 9% hurdle rate.

Value Investor Verdict

✓ Low market hurdle: Easy for a wide-moat compounder to beat.

Autonomous Thesis Underwriting

Surveil CI with Mathematical Margin of Safety Rules

Set non-negotiable floor rules for The Cigna Group. If a newly filed quarterly 10-Q breaks your ROIC floor, operating margin boundary, or balance sheet leverage rules, receive an autonomous breach audit within 15 minutes.

Buffett Quality

ROIC > 15% • Margin > 15% • D/E < 0.5x

Margin Floor Guard

Current Margin 4% • Floor > 10%

Solvency Guard

Altman-Z > 2.6 • Current Ratio > 1.5x

Track CI & Set Alerts Browse S&P 500 Coverage

Frequently Asked Questions: The Cigna Group (CI) Intrinsic Valuation

Audited fundamentals, DCF intrinsic value sensitivity, and thesis break detection parameters for The Cigna Group.

Based on institutional multi-stage Discounted Cash Flow (DCF) modeling on audited SEC cash flows, The Cigna Group has an estimated DCF intrinsic fair value of $480.64 per share compared to its current market price of $280.76. This represents an estimated 41.6% margin of safety (trading below fair value). Additionally, its classic Benjamin Graham Number stands at $296.47.